1 - 10 out of 22Page size: 10
  1. 2023

  2. Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

    Garrelfs, S. F., Metry, E. L., van Harskamp, D., Vaz, F. M., van den Akker, C. H. P., Schierbeek, H., Groothoff, J. W. & Oosterveld, M. J. S., May 2023, In: Kidney international. 103, 5, p. 990-993 4 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1

    Metry, E. L., Garrelfs, S. F., Peters-Sengers, H., Vaz, F. M., Bijlsma, J. A., Neradova, A., Oosterveld, M. J. S. & Groothoff, J. W., 10 Mar 2023, In: Nephrology Dialysis Transplantation.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope

    Groothoff, J. W., Metry, E., Deesker, L., Garrelfs, S., Acquaviva, C., Almardini, R., Beck, B. B., Boyer, O., Cerkauskiene, R., Ferraro, P. M., Groen, L. A., Gupta, A., Knebelmann, B., Mandrile, G., Moochhala, S. S., Prytula, A., Putnik, J., Rumsby, G., Soliman, N. A., Somani, B., & 1 othersBacchetta, J., Mar 2023, In: Nature reviews. Nephrology. 19, 3, p. 194-211 18 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2022

  6. The retinal phenotype in primary hyperoxaluria type 2 and 3

    Birtel, J., Diederen, R. M., Herrmann, P., Kaspar, S., Beck, B. B., Garrelfs, S. F., Hoppe, B. & Charbel Issa, P., 19 Oct 2022, (E-pub ahead of print) In: Pediatric nephrology (Berlin, Germany).

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry

    Deesker, L. J., Garrelfs, S. F., Mandrile, G., Oosterveld, M. J. S., Cochat, P., Deschênes, G., Harambat, J. R., Hulton, S-A., Gupta, A., Hoppe, B., Beck, B. B., Collard, L., Topaloglu, R., Prikhodina, L., Salido, E., Neuhaus, T., Groothoff, J. W. & Bacchetta, J., Jul 2022, In: Kidney International Reports. 7, 7, p. 1608-1618 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Primary hyperoxaluria: the pediatric nephrologist's point of view

    Ben-Shalom, E., Garrelfs, S. F. & Groothoff, J. W., 1 May 2022, In: Clinical kidney journal. 15, p. I23-I28

    Research output: Contribution to journal › Review article › Academic › peer-review

  9. Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Hulton, S. A., Groothoff, J. W., Frishberg, Y., Koren, M. J., Overcash, J. S., Sellier-Leclerc, A-L., Shasha-Lavsky, H., Saland, J. M., Hayes, W., Magen, D., Moochhala, S. H., Coenen, M., Simkova, E., Garrelfs, S. F., Sas, D. J., Meliambro, K. A., Ngo, T., Sweetser, M. T., Habtemariam, B. A., Gansner, J. M., & 2 othersMcGregor, T. L. & Lieske, J. C., Mar 2022, In: Kidney International Reports. 7, 3, p. 494-506 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry

    OxalEurope Consortium, Feb 2022, In: Kidney International Reports. 7, 2, p. 210-220 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Genetic assessment in primary hyperoxaluria: why it matters

    on behalf of the OxalEurope Consortium/Erknet Guideline Workgroup On Hyperoxaluria, 2022, (E-pub ahead of print) In: Pediatric nephrology (Berlin, Germany).

    Research output: Contribution to journal › Review article › Academic › peer-review

  12. Primary hyperoxaluria: No longer stuck between a rock and a hard place?

    Garrelfs, S. F., 2022, 361 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Previous 1 2 3 Next

ID: 111142